Nutraceutical COMP-4 confers protection against endothelial dysfunction through the eNOS/iNOS-NO-cGMP pathway.

Area of Science:

• Cardiovascular Research
• Endothelial Cell Biology
• Nutraceutical Science

Background:

• Nitric oxide (NO) plays a crucial role in vascular endothelial function.
• Endothelial dysfunction is linked to inflammation and prothrombotic states.
• Nutraceuticals are explored for their potential to support vascular health.

Purpose of the Study:

• To investigate the effect of COMP-4 on vascular endothelial cells.
• To determine if COMP-4 modulates nitric oxide (NO) production and endothelial function.
• To assess COMP-4's impact on inflammation and PAI-1 activity.

Main Methods:

• Human umbilical arterial endothelial cells were treated with COMP-4.
• Cells were exposed to hydrogen peroxide (H2O2) to induce oxidative stress.
• Measurements included NO, cGMP, nitric oxide synthase (NOS) isoforms, cytokines, and PAI-1.

Main Results:

• COMP-4 increased endothelial cell NO and cGMP production.
• COMP-4 upregulated endothelial NOS (eNOS) and inducible NOS (iNOS) expression.
• COMP-4 reduced pro-inflammatory cytokines and PAI-1 activity, mitigating H2O2-induced damage.

Conclusions:

• COMP-4 stimulates eNOS and iNOS, enhancing NO bioavailability.
• COMP-4 demonstrates protective effects on endothelial cells against oxidative stress.
• COMP-4 may reduce vascular inflammation and prothrombotic potential.